Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation

被引:33
|
作者
Patel, P. [1 ,2 ,3 ]
Gupta, P. K. C. [1 ,2 ,3 ]
White, C. M. J. [2 ,4 ]
Stanley, A. G. [4 ]
Williams, B. [5 ,6 ]
Tomaszewski, M. [2 ,3 ,4 ]
机构
[1] Univ Hosp Leicester NHS Trust, Dept Metab Med & Chem Pathol, Leicester, Leics, England
[2] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England
[3] Glenfield Gen Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England
[4] Univ Hosp Leicester NHS Trust, Leicester, Leics, England
[5] UCL, Inst Cardiovasc Sci, London, England
[6] Univ Coll London Hosp, Biomed Res Ctr, NIHR, London, England
基金
英国医学研究理事会;
关键词
TREATMENT-RESISTANT HYPERTENSION; SYMPATHETIC DENERVATION; ADHERENCE; URINE; ELIGIBILITY; MEDICATION; TRIAL; DRUGS;
D O I
10.1038/jhh.2015.103
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Renal denervation is a potential therapeutic option for resistant hypertension. A thorough clinical assessment to exclude reversible/spurious causes of resistance to antihypertensive therapy is required prior to this procedure. The extent to which non-adherence to antihypertensive treatment contributes to apparent resistance to antihypertensive therapy in patients considered for renal denervation is not known. Patients (n = 34) referred for renal denervation entered the evaluation pathway that included screening for adherence to antihypertensive treatment by high-performance liquid chromatography-tandem mass spectrometry-based urine analysis. Biochemical non-adherence to antihypertensive treatment was the most common cause of non-eligibility for renal denervation-23.5% of patients were either partially or completely non-adherent to prescribed antihypertensive treatment. About 5.9% of those referred for renal denervation had admitted non-adherence prior to performing the screening test. Suboptimal pharmacological treatment of hypertension and 'white-coat effect' accounted for apparently resistant hypertension in a further 17.7 and 5.9% of patients, respectively. Taken together, these three causes of pseudo-resistant hypertension accounted for 52.9% of patients referred for renal denervation. Only 14.7% of referred patients were ultimately deemed eligible for renal denervation. Without biochemical screening for therapeutic non-adherence, the eligibility rate for renal denervation would have been 38.2%. Non-adherence to antihypertensive treatment and other forms of therapeutic pseudo-resistance are by far the most common reason of 'resistant hypertension' in patients referred for renal denervation. We suggest that inclusion of biochemical screening for non-adherence to antihypertensive treatment may be helpful in evaluation of patients with 'resistant hypertension' prior to consideration of renal denervation.
引用
收藏
页码:368 / 373
页数:6
相关论文
共 50 条
  • [1] Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial
    Azizi, Michel
    Pereira, Helena
    Hamdidouche, Idir
    Gosse, Philippe
    Monge, Matthieu
    Bobrie, Guillaume
    Delsart, Pascal
    Mounier-Vehier, Claire
    Courand, Pierre-Yves
    Lantelme, Pierre
    Denolle, Thierry
    Dourmap-Collas, Caroline
    Girerd, Xavier
    Halimi, Jean Michel
    Zannad, Faiez
    Ormezzano, Olivier
    Vaisse, Bernard
    Herpin, Daniel
    Ribstein, Jean
    Chamontin, Bernard
    Mourad, Jean-Jacques
    Ferrari, Emile
    Plouin, Pierre-Francois
    Jullien, Vincent
    Sapoval, Marc
    Chatellier, Gilles
    CIRCULATION, 2016, 134 (12) : 847 - 857
  • [2] How to Screen for Non-Adherence to Antihypertensive Therapy
    Gupta, Pankaj
    Patel, Prashanth
    Horne, Robert
    Buchanan, Heather
    Williams, Bryan
    Tomaszewski, Maciej
    CURRENT HYPERTENSION REPORTS, 2016, 18 (12)
  • [3] Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation
    Schmieder, Roland E.
    Ott, Christian
    Schmid, Axel
    Friedrich, Stefanie
    Kistner, Iris
    Ditting, Tilmann
    Veelken, Roland
    Uder, Michael
    Toennes, Stefan W.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02): : 1 - 11
  • [4] Lessons learned from conducting a randomized controlled trial to improve non-adherence to antihypertensive drug treatment
    Peeters, L. E. J.
    van Gelder, T.
    van Dijk, L.
    Koch, B. C. P.
    Versmissen, J.
    BLOOD PRESSURE, 2023, 32 (01)
  • [5] Initial non-adherence to antihypertensive medications in the United States: a systematic literature review
    Cooke, Catherine E.
    Xing, Shan
    Gale, Stormi E.
    Peters, Sadie
    JOURNAL OF HUMAN HYPERTENSION, 2022, 36 (01) : 3 - 13
  • [6] Factors associated with antihypertensive medication non-adherence: a systematic review
    van der Laan, D. M.
    Elders, P. J. M.
    Boons, C. C. L. M.
    Beckeringh, J. J.
    Nijpels, G.
    Hugtenburg, J. G.
    JOURNAL OF HUMAN HYPERTENSION, 2017, 31 (11) : 687 - 694
  • [7] Non-adherence to antihypertensive medication: The role of mental and physical comorbidity
    Calderon-Larranaga, Amaia
    Diaz, Esperanza
    Poblador-Plou, Beatriz
    Andres Gimeno-Feliu, Luis
    Maria Abad-Diez, Jose
    Prados-Torres, Alexandra
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 207 : 310 - 316
  • [8] Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid Stenosis
    Haley, William
    Shawl, Fayaz
    Sternbergh, W. Charles
    Turan, Tanya N.
    Barrett, Kevin
    Voeks, Jenifer
    Brott, Thomas
    Meschia, James F.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (08):
  • [9] Renal Denervation in Patients With Uncontrolled Hypertension and Confirmed Adherence to Antihypertensive Medications
    Hameed, Mohammed Awais
    Pucci, Mark
    Martin, Una
    Watkin, Richard
    Doshi, Sagar
    Freedman, Jonathan
    Riley, Peter
    Townend, Jonathan
    Crowe, Paul
    Lipkin, Graham
    Dasgupta, Indranil
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (06): : 565 - 571
  • [10] A pharmacodynamic assessment of the impact of antihypertensive non-adherence on blood pressure control
    Choo, PW
    Rand, CS
    Inui, TS
    Lee, MLT
    Ma, CC
    Platt, R
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2000, 9 (07) : 557 - 563